Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

c-Myc inhibition negatively impacts lymphoma growth.

Gomez-Curet I, Perkins RS, Bennett R, Feidler KL, Dunn SP, Krueger LJ.

J Pediatr Surg. 2006 Jan;41(1):207-11; discussion 207-11.

PMID:
16410134
[PubMed - indexed for MEDLINE]
2.

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ.

Cancer Res. 2007 Oct 15;67(20):9762-70.

PMID:
17942906
[PubMed - indexed for MEDLINE]
Free Article
3.

Development of a real-time reverse transcription polymerase chain reaction assay for c-myc expression that allows the identification of a subset of c-myc+ diffuse large B-cell lymphoma.

Sáez AI, Artiga MJ, Romero C, Rodríguez S, Cigudosa JC, Pérez-Rosado A, Fernández I, Sánchez-Beato M, Sánchez E, Mollejo M, Piris MA.

Lab Invest. 2003 Feb;83(2):143-52.

PMID:
12594230
[PubMed - indexed for MEDLINE]
4.

Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis.

Kaptein JS, Lin CK, Wang CL, Nguyen TT, Kalunta CI, Park E, Chen FS, Lad PM.

J Biol Chem. 1996 Aug 2;271(31):18875-84.

PMID:
8702548
[PubMed - indexed for MEDLINE]
Free Article
5.

The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.

Klapproth K, Sander S, Marinkovic D, Baumann B, Wirth T.

Blood. 2009 Sep 17;114(12):2448-58. doi: 10.1182/blood-2008-09-181008. Epub 2009 Jul 23.

PMID:
19628709
[PubMed - indexed for MEDLINE]
Free Article
6.

Silencing of human c-myc oncogene expression by poly-DNP-RNA.

Shen L, Zhang C, Ambrus JL, Wang JH.

Oligonucleotides. 2005 Spring;15(1):23-35.

PMID:
15788898
[PubMed - indexed for MEDLINE]
7.

A polymerase chain reaction assay for simultaneous detection and quantitation of proto-oncogene and GAPD mRNAs in different cell growth rates.

Goswami PC, Albee LD, Spitz DR, Ridnour LA.

Cell Prolif. 1997 Jun-Jul;30(6-7):271-82.

PMID:
9451418
[PubMed - indexed for MEDLINE]
8.

The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.

Cotta CV, Leventaki V, Atsaves V, Vidaki A, Schlette E, Jones D, Medeiros LJ, Rassidakis GZ.

Cancer. 2008 Feb 1;112(3):552-61.

PMID:
18085637
[PubMed - indexed for MEDLINE]
Free Article
9.

A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8164-9. Epub 2003 Jun 13.

PMID:
12808131
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.

Habel ME, Lemieux R, Jung D.

J Cell Physiol. 2005 Apr;203(1):277-85.

PMID:
15468060
[PubMed - indexed for MEDLINE]
11.

c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs.

Abaza MS, Al-Saffar A, Al-Sawan S, Al-Attiyah R.

Tumour Biol. 2008;29(5):287-303. doi: 10.1159/000156706. Epub 2008 Sep 19.

PMID:
18802399
[PubMed - indexed for MEDLINE]
12.
13.

Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.

Schlott T, Eiffert H, Bohne W, Landgrebe J, Brunner E, Spielbauer B, Knight B.

Gynecol Oncol. 2005 Sep;98(3):409-19.

PMID:
16005053
[PubMed - indexed for MEDLINE]
14.

Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.

Wang Z, Ge L, Wang M, Carr BI.

J Cell Physiol. 2006 Jul;208(1):133-40.

PMID:
16596619
[PubMed - indexed for MEDLINE]
15.

Identification of novel Myc target genes with a potential role in lymphomagenesis.

Marinkovic D, Marinkovic T, Kokai E, Barth T, Möller P, Wirth T.

Nucleic Acids Res. 2004 Oct 11;32(18):5368-78. Print 2004.

PMID:
15477387
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.

Ott CJ, Kopp N, Bird L, Paranal RM, Qi J, Bowman T, Rodig SJ, Kung AL, Bradner JE, Weinstock DM.

Blood. 2012 Oct 4;120(14):2843-52. doi: 10.1182/blood-2012-02-413021. Epub 2012 Aug 17.

PMID:
22904298
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.

von Bueren AO, Shalaby T, Oehler-Jänne C, Arnold L, Stearns D, Eberhart CG, Arcaro A, Pruschy M, Grotzer MA.

BMC Cancer. 2009 Jan 10;9:10. doi: 10.1186/1471-2407-9-10.

PMID:
19134217
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.

Mossafa H, Damotte D, Jenabian A, Delarue R, Vincenneau A, Amouroux I, Jeandel R, Khoury E, Martelli JM, Samson T, Tapia S, Flandrin G, Troussard X.

Leuk Lymphoma. 2006 Sep;47(9):1885-93.

PMID:
17065002
[PubMed - indexed for MEDLINE]
19.

c-Myc overexpression and endocrine resistance in breast cancer.

McNeil CM, Sergio CM, Anderson LR, Inman CK, Eggleton SA, Murphy NC, Millar EK, Crea P, Kench JG, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Henshall SM, Musgrove EA, Sutherland RL.

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):147-55. Epub 2006 Oct 18.

PMID:
17052904
[PubMed - indexed for MEDLINE]
20.

C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma.

Schlee M, Hölzel M, Bernard S, Mailhammer R, Schuhmacher M, Reschke J, Eick D, Marinkovic D, Wirth T, Rosenwald A, Staudt LM, Eilers M, Baran-Marszak F, Fagard R, Feuillard J, Laux G, Bornkamm GW.

Int J Cancer. 2007 Apr 1;120(7):1387-95.

PMID:
17211884
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk